Sign in
CompletedPhase 3

Vonoprazan for Helicobacter Pylori Eradication in Adolescents

Key facts

Who runs it
Alexandria University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 3
People taking part
242 people enrolled
Started
1 Jan 2024
Ended
1 Aug 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Vonoprazan
  • Amoxicillin
  • Clarithromycin
  • Esomeprazole
Record updated
28 August 2024

Who can take part

Age
10 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Children in the age group (10-18 years), both genders, referred with dyspeptic complaints such as heartburn, dyspepsia, nausea, and epigastric pain
  • Who is positive for H. Pylori infection by a standardized diagnostic test
  • Pediatric patients with a clinical, laboratory, and endoscopic diagnosis of H.P.-positive gastritis and the other conditions necessary for H.P. eradication according to the Maastricht V consensus report

Who cannot take part

  • previous attempts to eradicate H.P
  • Use of antibiotics, acid-suppression, bismuth, or probiotics 4 weeks before enrollment
  • allergy to any of the drugs used in the study
  • Children with conditions that affect medication absorption e.g. celiac or Crohn's disease
  • Liver or kidney failure
  • symptoms suggestive of functional disorders

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The trial tends to evaluate the efficacy of vonoprazan-based triple therapy in eradicating H. Pylori infection in adolescent patients in Egypt, in comparison to standard treatment regimens to determine if it offers superior eradication rates (VONTAPE trial).

The 2 groups in the trial

  • Vonoprazan-based triple therapyTreatment being tested

    Vonoprazan tablets 20 mg twice daily plus Amoxicillin 50 mg/kg/day capsules or suspension \[maximum daily dose 2 g\] plus Clarithromycin 20 mg/kg/day tablets or suspension \[maximum daily dose 1 g\] The triple combination will be given for 14 days

    Treatment: Vonoprazan, Amoxicillin, and Clarithromycin

  • Proton pump-based triple therapy "standard triple therapy"Existing treatment, for comparison

    Esomeprazole tablets \[20 mg/day if \< 30 kg and 40 mg/daily if ≥ 30 kg\] on two divided daily doses plus Amoxicillin 50 mg/kg/day capsules or suspension \[maximum daily dose 2 g\] plus Clarithromycin 20 mg/kg/day tablets or suspension \[maximum daily dose 1 g\] The triple combination will be given for 14 days

    Treatment: Amoxicillin, Clarithromycin, and Esomeprazole

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Vonoprazan-based Triple Therapy vs. Standard Triple Therapy for Helicobacter Pylori Eradication in Adolescents: A Randomized, Double-blinded Controlled Trial
Publications
Record updated
28 August 2024